| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.0075 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |